CB Therapeutics

Ibogaine is banned under the federal government's most restrictive category for illegal, high-risk drugs.

The agency's decision to hold an advisory committee meeting on the topic comes after HHS Secretary Robert F. Kennedy Jr. told podcaster Joe Rogan he's a

BASF is set to unveil a new chapter in collagen science at in-cosmetics Global in Paris. With the launch of two cosmetic actives, NeoHelix Regenerate and SkinNexus Collag3n, the company is emphasizing a comprehensive approach to skin rejuvenation.

Series B led by Bpifrance with Danone Ventures and Bel Group strategic. Yeast-produced casein at 74 lower emissions than conventional dairy.

Use of the psychoactive substance has shown promise in helping those suffering from PTSD and opioid withdrawal symptoms.

Real-world data on suzetrigine, the first new non-opioid analgesic class approved by FDA in 20+ years. Commercial validation of the non-opioid pain market.

AI-designed proteins, Virtual cells, Programmable RNA. Do business with GSK, Sanofi, Novo Nordisk, NVIDIA, OpenAI, P&G, Mars and Unilever. May 3-6, San Jose.

Newsfile Press Release.

Carlsbad, California--(Newsfile Corp. - May 2, 2024) - CB Therapeutics, a leading biotechnology firm specializing in precision fermentation, announces groundbreaking advancements in the production of pharmaceutical-grade cannabinoids and their analogs. Wi